DNA-based testing for human papillomavirus (HPV) has been shown to be more effective than today’s commonly used screening methods aimed at detecting and preventing cervical cancer, a major cause of death among women worldwide. The recently published “WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention” recommends the use of such DNA-based HPV testing as a first choice screening method.
